Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
Article in Cochrane Database of Systematic Reviews (July 2023)
The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.
Article in Cochrane Database of Systematic Reviews (July 2023)
Article in Journal of Clinical Medicine (March 2022)
Article in Cell Insight (February 2022)